Reinet: NAV stable at €36.26 per share thanks to buybacks, profit of €157M
Reinet Investments published on 18 November 2026 its unaudited half-year accounts as of 30 September 2026. The net asset value (NAV) of the Luxembourg holding company fell by €230M, or 3.5%, to €6,371M, while the net profit for the half-year amounted to €157M.
Relative to the number of shares outstanding, the NAV remained virtually stable at €36.26, compared with €36.31 at the end of March.
The decline in total NAV is mainly due to the €143M spent on share buybacks, the €166M liability recorded for future buybacks and the €78M dividend, while the reduction in the number of shares outstanding supports the NAV per share. Excluding this liability, the adjusted NAV reaches €6,537M, or €37.21 per share.
The decline in net assets is due to share buybacks and the dividend
Over the half-year, Reinet repurchased 6,093,269 shares. The number of shares outstanding, excluding treasury shares, thus fell from 181,790,891 to 175,697,622, which explains why a 3.5% decline in net assets results in an almost unchanged NAV per share.
The sixth programme, carried out from 22 June to 28 July 2026, covered 2.5 million shares for €59M. The seventh, launched on 18 August for a maximum of 8 million shares and €250M until 15 December 2026, had totalled 3,593,269 shares repurchased for €84M as of 30 September.
In accordance with IAS 32, the company recorded a liability of €166M corresponding to the maximum amount remaining to be committed under this programme.
Conversely, upward revaluations of certain assets contributed €103M, and interest and other movements €60M, compared with €6M of write-downs on Trilantic Capital Partners and the NanoDimension funds.
Profit of €157M excluding Pension Corporation dividends
Net profit rose from a loss of €190M in the first half of the previous financial year to a profit of €157M. Total income, however, fell from €427M to €62M, as the comparison period included €303M of dividends from Pension Corporation, a holding fully sold during the financial year ended 31 March 2026.
Interest and other investment income doubled, from €33M to €66M. Fair value adjustments on other investments came to +€94M, compared with -€106M a year earlier, and the currency effect on cash was +€12M, compared with -€81M.
Expenses fell from €52M to €11M. No performance fee was accrued, compared with €25M a year earlier, and the management fee dropped from €23M to €7M.
According to the company, this decline is mainly due to the composition of net assets, which were 83% liquid as of 31 March 2026, compared with 26% a year earlier.
Cash of €5,149M and a share price down 14.5%
Cash and liquid investments reached €5,149M, or 80.8% of net assets, compared with 83.0% at the end of March.
The weight of investments rose from 19.3% to 22.0%, to €1,402M, driven by TruArc Partners (€376M versus €331M, including €39M of contributions), the Coatue funds (€247M versus €217M) and the listed holding Twist Bioscience (€76M versus €18M).
Commitments yet to be funded amount to €520M, of which 65.5% relate to TruArc Partners, after €59M paid during the period. The dividend paid in September 2026 was increased to €0.435 per share, compared with €0.37 a year earlier.
On the stock market, the indicative share price in Luxembourg fell 14.5% over the half-year, from €27.60 to €23.60. The total shareholder return since inception stands at 7.7% per year, compared with 8.8% at the end of March, while the compound annual growth rate of NAV since March 2009 is 8.2%, compared with 8.5%.
At the end of September, the share price was thus below the NAV per share, as well as below the €28.09 threshold that the volume-weighted average price over the last twenty trading days of the financial year would need to exceed for a performance fee to be due on 31 March 2027.